A Case Report: Side Effect Of Linezolid In Pulmonary Rifampicin Resistance Tuberculosis

Syazili Mustofa, Salwa Al Karina, Giska Tri Putri, Hendri Busman, Muhammad Addin Syakir

Sari


Linezolid is a very potent treatment for pulmonary tuberculosis, but it has some side effects. Patients with drug-resistant pulmonary tuberculosis may experience anemia as a side effect of taking the multidrug-resistant tuberculosis medication Linezolid. A 58-year-old man's primary complaint in one case reported to RSUD dr. H. Abdul Moeloek Lampung was a weakness. The diagnosis was made based on anamnesis, a physical examination, and supporting examinations. Treatment was given both pharmacologically and non-pharmacologically, including the intervention to discontinue Linezolid. Although linezolid-based combination therapy in program conditions is associated with favorable outcomes, side effects should be monitored closely, which may require discontinuation of the drug and taking appropriate steps to treat side effects.

 


Kata Kunci


Anemia; Linezolid; Pulmonary TB

Teks Lengkap:

PDF

Referensi


Alffenaar, J.C., Akkerman, O.W., Anthony, R.M., Tiberi, S., Heysell, S., Grobusch, M.P., Cobelens, F.G. and Van Soolingen, D. (2017). 'Individualizing management of extensively drug-resistant tuberculosis: diagnostics, treatment, and biomarkers,' Expert Review of Anti-infective Therapy, 15, pp. 11−21.

Cavalhiero, A.P., Marcos, R., Lessa, F., and Sperhacke, R.D. (2020) 'Tuberculosis', in Magill, A.J. et al. (eds.) Hunter’s Tropical Medicine and Emerging Infectious Diseases. Philadelphia: Elsevier, pp. 454–471.

Dasaradhan, T., Koneti, J., Kalluru, R., Gadde, S., Cherukuri, S.P., and Chikatimalla, R. (2022). 'Tuberculosis-Associated Anemia: A Narrative Review,' Cureus, 14(8), p. e27746. doi: 10.7759/cureus.27746.

Huang, Y., Pang, Y., Liu, Y., and Zhu, Y. (2022). 'Review and Updates on the Diagnosis of Tuberculosis,' Journal of Clinical Medicine, 11(19), p. 5826.

Khawbung, J.L., Nath, D. & Chakraborty, S. (2021). 'Drug-resistant Tuberculosis: A review,' Comparative Immunology, Microbiology & Infectious Diseases, 74, p. 101574. doi: 10.1016/j.cimid.2020.101574.

Lee, M., Lee, J., Carroll, M.W., Choi, H., Min, S., Song, T., et al. (2012). 'Linezolid for treatment of chronic extensively drug-resistant tuberculosis,' New England Journal of Medicine, 367(16), pp. 1508–1518.

Lin, H., Shin, S., Blaya, J.A., Zhang, Z., Cegielski, P., Contreras, C., Asensio, L., Bonilla, C., Bayona, J., Paciorek, C.J. and Cohen, T. (2011). 'Assessing spatiotemporal patterns of multidrug-resistant and drug-sensitive tuberculosis in a South American setting,' Epidemiology and Infection, 139, pp. 1784−1793.

Louis, J., Casarett, J., Curtis, D., Klaassen, C.D. (2008). Casarett and Doull's Toxicology: The Basic Science of Poisons. 7th ed. New York: McGraw-Hill Professional.

Marcu, D.T.M., Singu, P., Papp, M., and Erős, E. (2023). 'Cardiovascular Involvement in Tuberculosis: From Pathophysiology to Diagnosis and Complications: ', Diagnostics, 13(3), p. 432.

Millard, J., Pertinez, H., Bonnett, L., Hodel, E.M., Dartois, V., Johnson, J.L., et al. (2018). 'Linezolid pharmacokinetics in MDR-TB: A systematic review, meta-analysis, and Monte Carlo simulation,' Journal of Antimicrobial Chemotherapy, 73, pp. 1755-1762.

Mustofa, S., NSPDL, P., Togihon, L., Aryana, W. F., Sanjaya, R. P., & Saputra, T. T. (2023). Laporan Kasus: Bronkiektasis Terinfeksi disertai Sindroma Obstruksi Pasca Tuberkulosis. Jurnal Majority, 12(1), 33-42.

Mustofa, S., & Adilla, P. (2024). Metode Molekuler untuk Mendeteksi Mikroba Penyebab Penyakit Patogen. Medical Profession Journal of Lampung, 14(2), 351-354.

Mustofa, S., Megantoro, G. K., Gozali, A., Saputra, T. T., & Sanjaya, R. P. (2023). Sindrom Obstruksi Pasca Tuberkulosis Dengan Luluh Lobus: Laporan Kasus. Jurnal Ilmu Kedokteran dan Kesehatan, 10(7), 2426-2430.

Mustofa, S., & Antoni, A. (2023). Case Report: Unilateral Secondary Spontaneous Pneumothorax Caused by Pulmonary Tuberculosis in a Heavy Smoker. Sriwijaya Journal of Medicine, 6(3), 87-93.

Nachiappan, A.C., Rahbar, K., Shi, X., Guy, E.S., Mortani Barbosa, E.J. Jr., Shroff, G.S., Ocazionez, D., Schlesinger, A.E., Katz, S.I. and Hammer, M.M. (2017) 'Pulmonary Tuberculosis: Role of Radiology in Diagnosis and Management', Radiographics, 37(1), pp. 52-72. Doi:

1148/rg.2017160032.

Ramachandran, G.S. & Swaminathan, S. (2015). 'Safety and tolerability profile of second-line anti-tuberculosis medications,' Drug Safety Journal, 38(3), pp. 253–269.

Sahiratmadja, E., Wieringa, F.T., van Crevel, R., et al. (2007). 'Iron deficiency and NRAMP1 polymorphisms (INT4, D543N and 3'UTR) do not contribute to the severity of anemia in tuberculosis in the Indonesian population', British Journal of Nutrition, 98, pp. 684–690. doi: 10.1017/S0007114507742691.

Shah, N.S., et al. (2017). 'Transmission of Extensively Drug-Resistant Tuberculosis in South Africa,' New England Journal of Medicine, 376, pp. 243−253.

WHO. (2011) Guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Geneva: World Health Organization.

WHO. (2016) Treatment Guidelines for Drug-Resistant Tuberculosis - 2016 update. Geneva: World Health Organization.

WHO. (2018) Rapid communication: key changes to the treatment of multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB). Geneva: World Health Organization.

WHO. (2020) Global Tuberculosis Report. Geneva: World Health Organization.

Xu, H.B., Jiang, R.H., Li, L. and Xiao, H.P. (2012). 'Linezolid in the treatment of MDR-TB: a retrospective clinical study,' International Journal of Tuberculosis and Lung Disease, 16(3), pp. 358-363. doi: 10.5588/ijtld.11.0493.




DOI: https://doi.org/10.33024/jikk.v12i1.18144

Refbacks

  • Saat ini tidak ada refbacks.


##submission.copyrightStatement##

##submission.license.cc.by-nc4.footer##

Pendidikan Dokter Universitas Malahayati Lampung


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.